Copyright
©The Author(s) 2018.
World J Diabetes. Jan 15, 2018; 9(1): 25-32
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.25
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.25
Table 2 Influence of obestatin on antilipolytic and glucose transport activities of human subcutaneous adipocytes
n | Treatment | Control | Obestatin 1 nmol/L | Obestatin 10 nmol/L | Obestatin 100 nmol/L | UK14304 1 μmol/L | |
Lipolysis, µmol glycerol/ 100 mg lipid/90 min | 3 | Isoprenaline | 0.64 ± 0.10 | 0.61 ± 0.09 | 0.62 ± 0.10 | 0.62 ± 0.10 | 0.29 ± 0.04a |
Glucose transport, nmol 2-DG/100 mg lipids/10 min | 10 | Insulin | 0.46 ± 0.14 | 0.45 ± 0.09 | 0.45 ± 0.09 | 0.43 ± 0.09 | ND |
- Citation: Carpéné C, Les F, Estève D, Galitzky J. Short-term effects of obestatin on hexose uptake and triacylglycerol breakdown in human subcutaneous adipocytes. World J Diabetes 2018; 9(1): 25-32
- URL: https://www.wjgnet.com/1948-9358/full/v9/i1/25.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i1.25